As you may already know I have more confidence in the safety and tolerability of mRNA combination vaccines as opposed to protein-based. We will know more this quarter (fingers crossed).
Let's face it, the threat of mRNA combination vaccines forced companies like GSK, PFE, and SNY to explore the idea of combinations to remain competitive.
Market Data 
Markets 
AI
